Spyre Therapeutics, Inc.SYRENASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank92
Studio
Year-over-Year Change

Return on equity

Latest
-21.70%
↑ 74% vs avg
Percentile
P92
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-83.34%
Historical baseline
PeriodValueYoY Change
2025-21.70%+46.0%
2024-40.17%+78.2%
2023-184.11%-10.5%
2022-166.61%-112.5%
2021-78.39%-35.5%
2020-57.85%+55.6%
2019-130.25%-98.0%
2018-65.77%-21.6%
2017-54.11%-57.0%
2016-34.46%-